Cargando…

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

During anti-retroviral therapy (ART) HIV-1 persists in cellular reservoirs, mostly represented by CD4+ memory T cells. Several approaches are currently being undertaken to develop a cure for HIV-1 infection through elimination (or reduction) of these reservoirs. Few studies have so far been conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekele, Yonas, Graham, Rebecka Lantto, Soeria-Atmadja, Sandra, Nasi, Aikaterini, Zazzi, Maurizio, Vicenti, Ilaria, Naver, Lars, Nilsson, Anna, Chiodi, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767726/
https://www.ncbi.nlm.nih.gov/pubmed/29375579
http://dx.doi.org/10.3389/fimmu.2017.01966
_version_ 1783292579045965824
author Bekele, Yonas
Graham, Rebecka Lantto
Soeria-Atmadja, Sandra
Nasi, Aikaterini
Zazzi, Maurizio
Vicenti, Ilaria
Naver, Lars
Nilsson, Anna
Chiodi, Francesca
author_facet Bekele, Yonas
Graham, Rebecka Lantto
Soeria-Atmadja, Sandra
Nasi, Aikaterini
Zazzi, Maurizio
Vicenti, Ilaria
Naver, Lars
Nilsson, Anna
Chiodi, Francesca
author_sort Bekele, Yonas
collection PubMed
description During anti-retroviral therapy (ART) HIV-1 persists in cellular reservoirs, mostly represented by CD4+ memory T cells. Several approaches are currently being undertaken to develop a cure for HIV-1 infection through elimination (or reduction) of these reservoirs. Few studies have so far been conducted to assess the possibility of reducing the size of HIV-1 reservoirs through vaccination in virologically controlled HIV-1-infected children. We recently conducted a vaccination study with a combined hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccine in 22 HIV-1-infected children. We assessed the size of the virus reservoir, measured as total HIV-1 DNA copies in blood cells, pre- and postvaccination. In addition, we investigated by immunostaining whether the frequencies of CD4+ and CD8+ T cells and parameters of immune activation and proliferation on these cells were modulated by vaccination. At 1 month from the last vaccination dose, we found that 20 out of 22 children mounted a serological response to HBV; a majority of children had antibodies against HAV at baseline. The number of HIV-1 DNA copies in blood at 1 month postvaccination was reduced in comparison to baseline although this reduction was not statistically significant. A significant reduction of HIV-1 DNA copies in blood following vaccination was found in 12 children. The frequencies of CD4+ (naïve, effector memory) and CD8+ (central memory) T-cell subpopulations changed following vaccinations and a reduction in the activation and proliferation pattern of these cells was also noticed. Multivariate linear regression analysis revealed that the frequency of CD8+ effector memory T cells prior to vaccination was strongly predictive of the reduction of HIV-1 DNA copies in blood following vaccination of the 22 HIV-1-infected children. The results of this study suggest a beneficial effect of vaccination to reduce the size of virus reservoir in HIV-1-infected children receiving ART. A reduced frequency of activated CD4+ cells and an increase in central memory CD8+ T cells were associated with this finding. Further studies should assess whether vaccination is a possible tool to reduce HIV-1 reservoirs.
format Online
Article
Text
id pubmed-5767726
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57677262018-01-26 Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs? Bekele, Yonas Graham, Rebecka Lantto Soeria-Atmadja, Sandra Nasi, Aikaterini Zazzi, Maurizio Vicenti, Ilaria Naver, Lars Nilsson, Anna Chiodi, Francesca Front Immunol Immunology During anti-retroviral therapy (ART) HIV-1 persists in cellular reservoirs, mostly represented by CD4+ memory T cells. Several approaches are currently being undertaken to develop a cure for HIV-1 infection through elimination (or reduction) of these reservoirs. Few studies have so far been conducted to assess the possibility of reducing the size of HIV-1 reservoirs through vaccination in virologically controlled HIV-1-infected children. We recently conducted a vaccination study with a combined hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccine in 22 HIV-1-infected children. We assessed the size of the virus reservoir, measured as total HIV-1 DNA copies in blood cells, pre- and postvaccination. In addition, we investigated by immunostaining whether the frequencies of CD4+ and CD8+ T cells and parameters of immune activation and proliferation on these cells were modulated by vaccination. At 1 month from the last vaccination dose, we found that 20 out of 22 children mounted a serological response to HBV; a majority of children had antibodies against HAV at baseline. The number of HIV-1 DNA copies in blood at 1 month postvaccination was reduced in comparison to baseline although this reduction was not statistically significant. A significant reduction of HIV-1 DNA copies in blood following vaccination was found in 12 children. The frequencies of CD4+ (naïve, effector memory) and CD8+ (central memory) T-cell subpopulations changed following vaccinations and a reduction in the activation and proliferation pattern of these cells was also noticed. Multivariate linear regression analysis revealed that the frequency of CD8+ effector memory T cells prior to vaccination was strongly predictive of the reduction of HIV-1 DNA copies in blood following vaccination of the 22 HIV-1-infected children. The results of this study suggest a beneficial effect of vaccination to reduce the size of virus reservoir in HIV-1-infected children receiving ART. A reduced frequency of activated CD4+ cells and an increase in central memory CD8+ T cells were associated with this finding. Further studies should assess whether vaccination is a possible tool to reduce HIV-1 reservoirs. Frontiers Media S.A. 2018-01-10 /pmc/articles/PMC5767726/ /pubmed/29375579 http://dx.doi.org/10.3389/fimmu.2017.01966 Text en Copyright © 2018 Bekele, Graham, Soeria-Atmadja, Nasi, Zazzi, Vicenti, Naver, Nilsson and Chiodi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bekele, Yonas
Graham, Rebecka Lantto
Soeria-Atmadja, Sandra
Nasi, Aikaterini
Zazzi, Maurizio
Vicenti, Ilaria
Naver, Lars
Nilsson, Anna
Chiodi, Francesca
Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
title Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
title_full Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
title_fullStr Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
title_full_unstemmed Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
title_short Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
title_sort hepatitis b virus vaccination in hiv-1-infected young adults: a tool to reduce the size of hiv-1 reservoirs?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767726/
https://www.ncbi.nlm.nih.gov/pubmed/29375579
http://dx.doi.org/10.3389/fimmu.2017.01966
work_keys_str_mv AT bekeleyonas hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT grahamrebeckalantto hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT soeriaatmadjasandra hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT nasiaikaterini hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT zazzimaurizio hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT vicentiilaria hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT naverlars hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT nilssonanna hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs
AT chiodifrancesca hepatitisbvirusvaccinationinhiv1infectedyoungadultsatooltoreducethesizeofhiv1reservoirs